Alzheimer's disease

M3 Biotechnology Begins Testing of Alzheimer’s Therapy in Adults with the Disease
CP Wire
Thu, 09/13/18 - 09:39 am
M3 Biotechnology
NDX-1017
Alzheimer's disease
M3 Biotechnology Begins Testing of Alzheimer’s Therapy in Adults with the Disease
Thu, 09/13/18 - 09:13 am
M3 Biotechnology
Alzheimer's disease
NDX-1017
Infectious Theory of Alzheimer's Disease Draws Fresh Interest
NPR
Mon, 09/10/18 - 12:12 am
infection
Alzheimer's disease
Eli Lilly's New PET Scan Offers Another Tool for Studying Alzheimer's
BioSpace
Fri, 09/7/18 - 11:02 am
Eli Lilly
Avid Radiopharmaceuticals
PET scans
tau
Alzheimer's disease
devices
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
BioSpace
Tue, 08/28/18 - 07:54 pm
Biogen
Eisai
aducanumab
clinical trials
Alzheimer's disease
Second time lucky? Alzheon tries for much-reduced IPO
Fierce Biotech
Tue, 08/28/18 - 10:33 am
Alzheon
IPOs
Alzheimer's disease
tramiprosate
Pain Therapeutics' Shares Rally on Alzheimer's Study Grant
Yahoo/Zacks.com
Thu, 08/16/18 - 12:52 pm
Pain Therapeutics
NIH
R&D
Alzheimer's disease
PTI-125
As Alzheimer’s drug developers give up on today’s patients, where is the outrage?
Stat
Wed, 08/15/18 - 09:43 am
patients
Alzheimer's disease
activists
Why Biogen's Stock Ripped Higher in July
Motley Fool
Mon, 08/13/18 - 09:41 am
Biogen
Eisai
BAN2401
Alzheimer's disease
Spinraza
Ionis Pharmaceuticals
Biogen’s high-stakes Alzheimer’s gamble is being roasted by the experts. Is the amyloid beta theory dead?
Endpoints
Thu, 08/9/18 - 09:16 am
Biogen
Eisai
BAN2401
Alzheimer's disease
FOCUS-Eisai/Biogen to advance Alzheimer's drug, provide fresh hope
Yahoo/Reuters
Sun, 08/5/18 - 12:22 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
How Bill Gates Could Transform Alzheimer's Disease
Forbes
Sat, 08/4/18 - 12:03 pm
Bill Gates
Gates Foundation
Alzheimer's disease
Karuna raises $42M to resurrect abandoned Lilly drug for schizophrenia
Fierce Biotech
Thu, 08/2/18 - 09:56 am
Karuna Pharmaceuticals
Eli Lilly
schizophrenia
Alzheimer's disease
KarXT
xanomeline
Microbiome Report for the week ending 7-29-18
CP Wire
Wed, 08/1/18 - 11:49 pm
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Microbiome Report for the week ending 7-29-18
Wed, 08/1/18 - 11:48 pm
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
Fortune
Mon, 07/30/18 - 11:55 pm
Biogen
Eisai
BAN2401
clinical trials
Alzheimer's disease
Brain’s lymphatic system, just recently discovered, now linked to aging and Alzheimer’s
Fierce Biotech
Sat, 07/28/18 - 12:30 pm
Alzheimer's disease
lymphatic system
drug discovery
R&D
Eisai, Biogen outline a 30% and 47% advantage for their Alzheimer’s drug BAN2401 — but critics drag stock down
Endpoints
Wed, 07/25/18 - 05:11 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
clinical trials
As Eisai, Biogen plot a course to accelerated approvals for Alzheimer’s drug, a mob of skeptics are waiting to decipher hard numbers
Endpoints
Tue, 07/24/18 - 11:30 am
Eisai
Biogen
Alzheimer's disease
BAN2401
AAIC
Sage Bionetworks Launches Platform to Crowdsource the Evaluation of Curated Alzheimer’s Disease Genomic Analysis
CP Wire
Fri, 07/20/18 - 09:40 am
Sage Bionetworks
Alzheimer's disease
genomic analysis
drug discovery
Agora platform

Pages